Innoviva acquired the LYNX platform from Lyndra Therapeutics and established Nortiva Bio as a subsidiary, utilizing science from Robert Langer's labs.
1 report, 1 independent
Updated Jul 1
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Innoviva acquired the LYNX platform from Lyndra Therapeutics and established Nortiva Bio as a subsidiary, utilizing science from Robert Langer's labs.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Robert Langer
German inorganic chemistry professor
Nothing else this week.